Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04289402 · ClinicalTrials.gov registry record · NA

Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease

A NA study of Aging and Alzheimer Dementia, sponsored by Hebrew SeniorLife.

Active
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT04289402 is a NA study of Aging and Alzheimer Dementia that is active but no longer recruiting, run by Hebrew SeniorLife. The registered enrollment target is 11 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04289402, a NA study of Aging and Alzheimer Dementia, is active but no longer recruiting, sponsored by Hebrew SeniorLife.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to conduct a pilot, randomized sham-controlled trials to determine the feasibility and effects of a 10-session personalized tDCS intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of mobility in 24 older adults with mild AD living in supportive housing.

Interventions

  • OTHER Active-Sham
  • OTHER Personalized tDCS

Study Locations (1)

Massachusetts

  • Hebrew Rehabilitation Center - Roslindale

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2020-01-31
Est. Completion 2026-01-31
Phase NA

Sponsor

Hebrew SeniorLife

32 total trials

What the Registry Record Tells You About NCT04289402

The ClinicalTrials.gov registry entry for NCT04289402 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Hebrew SeniorLife, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Active-Sham is the first listed.

NCT04289402 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT04289402 about?

NCT04289402 is a clinical study titled "Individualized Brain Stimulation to Improve Mobility in Alzheimer's Disease". The objective of this study is to conduct a pilot, randomized sham-controlled trials to determine the feasibility and effects of a 10-session personalized tDCS intervention targeting the left dorsolateral prefrontal cortex on cognitive function, dual task standing and walking, and other metrics of m...

What is the current status of trial NCT04289402?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 11 participants. The study started on 2020-01-31. Estimated completion is 2026-01-31.

What conditions does trial NCT04289402 study?

This clinical trial studies the following conditions: Aging, Alzheimer Dementia, Presenile Alzheimer Dementia.

What interventions are being tested in trial NCT04289402?

The interventions under investigation include: Active-Sham (OTHER), Personalized tDCS (OTHER).

Who is sponsoring clinical trial NCT04289402?

This trial is sponsored by Hebrew SeniorLife, which has 32 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04289402 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.